Trial Profile

A study of topical CGS-125 for treatment of subjects with osteoarthritic knee pain

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 27 Nov 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Capsaicin (Primary)
Indications Pain
Focus Adverse reactions; Therapeutic Use

Most Recent Events

27 Nov 2015 New trial record
23 Nov 2015 Results published in a CapGenesis Therapeutics media release.
23 Nov 2015 This study was conducted at a single site in the Dominican Republic under the supervision of an Institutional Review Board (IRB) and the National Council on Bioethics in Health (CONABIOS), which functions as a Dominican national IRB.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com